FDA Approved: BYLVAY — Original Application (Ipsen Biopharmaceuticals, Inc.)

View source ↗

Summary

FDA approved BYLVAY (odevixibat) from Ipsen Biopharmaceuticals as the original application for the treatment of progressive familial intrahepatic cholestasis in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Progressive Familial Intrahepatic Cholestasis

Drugs mentioned

• BYLVAY (odevixibat)

Snippet

ORIG AP for BYLVAY (ODEVIXIBAT)